SQUINTO STEPHEN P 4
4 · Passage BIO, Inc. · Filed Mar 2, 2020
Insider Transaction Report
Form 4
SQUINTO STEPHEN P
DirectorHead of Research and Dev
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-27+185,776→ 185,776 totalExercise: $18.00Exp: 2030-02-27→ Common Stock (185,776 underlying) - Award
Director Stock Option (Right to Buy)
2020-02-27+33,836→ 33,836 totalExercise: $18.00Exp: 2030-02-27→ Common Stock (33,836 underlying)
Footnotes (2)
- [F1]The option vests as to 25% of the total shares on February 27, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on February 27, 2024, subject to the reporting person's provision of service to the issuer on each vesting date.
- [F2]The option vest as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.